Cardiol Therapeutics Inc. (NASDAQ:CRDL) appears in 40 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 31 Mar, 2026 | 15,352,317 | 15,143,367 | 7,247.36% | $20,725,628.00 |
| Tejara Capital Ltd | 31 Mar, 2026 | 5,130,122 | 2,500,000 | 95.05% | $4,893,110.00 |
| Tejara Capital Ltd | 31 Mar, 2026 | 5,130,122 | 0 | 0.00% | $6,925,665.00 |
| Ikarian Capital, LLC | 31 Mar, 2026 | 2,725,000 | 2,725,000 | 0.00% | $3,678,750.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 819,904 | 819,904 | 0.00% | $1,106,871.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Mar, 2026 | 794,881 | 794,881 | 0.00% | $1,073,089.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 657,000 | 335,200 | 104.16% | $626,646.00 |
| AdvisorShares Investments LLC | 31 Mar, 2026 | 597,977 | 40,589 | 7.28% | $570,350.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 534,211 | 127,276 | 31.28% | $721,185.00 |
| INTEGRITY ALLIANCE, LLC. | 31 Mar, 2026 | 465,025 | 30,000 | 6.90% | $629,830.00 |
| INTEGRITY ALLIANCE, LLC. | 31 Mar, 2026 | 435,025 | 435,025 | 0.00% | $415,753.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 406,935 | 174,590 | 75.14% | $388,135.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 367,453 | -734,653 | -66.66% | $350,183.00 |
| Morgan Stanley | 31 Mar, 2026 | 344,463 | 188,132 | 120.34% | $328,549.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 332,400 | -324,600 | -49.41% | $448,740.00 |
| Morgan Stanley | 31 Mar, 2026 | 250,421 | -94,042 | -27.30% | $338,068.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 229,806 | 229,806 | 0.00% | $310,238.00 |
| MMCAP International Inc. SPC | 31 Mar, 2026 | 208,950 | -84,106 | -28.70% | $199,297.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Mar, 2026 | 203,726 | 110,328 | 118.13% | $194,314.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 151,517 | -392,800 | -72.16% | $143,942.00 |